Skip to main content
Toggle navigation
Search
Home
Clinical programs
Home
Clinical programs
Clinical programs
Type here to filter the list
(84) Facilitators for Implementation of Pharmacist Billing for Medication Therapy Management (MTM)
(85) Efficacy and safety of fixed-dose tavapadon, an oral, once-daily, selective D1/D5 dopamine agonist for the treatment of early Parkinson’s disease
(86) Efficacy and safety of flexible-dose tavapadon, an orally administered, once-daily, selective D1/D5 dopamine agonist for the treatment of early Parkinson’s disease
(87) Efficacy and safety of tavapadon, an orally administered, once-daily, selective D1/D5 dopamine agonist, adjunctive to levodopa for treatment of Parkinson’s disease with motor fluctuations
(88) Impact of a diabetes deprescribing detailing initiative among commercially insured members
(89) Validation of Long-term Savings from a Pharmacist-to-Prescriber Telephonic Intervention
(90) Transplant readiness achieved through novel solutions for obesity reduction and management
(91) Epinephrine delivered via sublingual film (Anaphylm) elicits rapid and consistent pharmacokinetic and pharmacodynamic responses
